INS and breast cancer: As insulin was found to down regulate maspin synthesis, it could perhaps be speculated the occurrence of type II diabetes mellitus that is reported to cause hyper insulinemia due to systemic insulin resistance might actually lead to worse prognostic outcome in breast cancer in patients with co occurrence of type II diabetes mellitus.